Forte Biosciences, Inc. Common Stock

FBRXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
16.52 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
16.53
↗ 0.01 (0.03%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
16.53
↗ 0.01 (0.03%)
🔴Market: CLOSED
Open?$16.37
High?$16.70
Low?$15.71
Prev. Close?$16.52
Volume?408.7K
Avg. Volume?242.0K
VWAP?$16.26
Rel. Volume?1.69x
Bid / Ask
Bid?$13.74 × 1.0K
Ask?$24.83 × 100
Spread?$11.09
Midpoint?$19.29
Valuation & Ratios
Market Cap?338.3M
Shares Out?20.5M
Float?7.5M
Float %?60.0%
P/E Ratio?N/A
P/B Ratio?8.04
EPS?-$3.70
Dividend?0.00%
Ex-Dividend?N/A

Forte Biosciences, Inc. Common Stock (FBRX) trades at $16.62 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, FBRX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Themes
Biotech - Drug Development›Immunology & AutoimmuneBiotech - Drug Development›Rare Disease Therapeutics
Employees
22
Market Cap
338.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fortebiorx.com
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
2
Momentum?
50
Short Sent.?
41
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.07Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.05%High
Short Interest?1.2M
Days to Cover?5.7
Free Float7.5M
Avg Daily Volume211.0K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.75Strong
Quick Ratio?2.75Strong
Cash Ratio?2.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
23
8.04HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-180.2%WEAK▾
ROA?
S&P
3
-112.8%WEAK▾
Cash Flow & Enterprise
FCF?$-59390000
Enterprise Value?$280.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist